Three-dimensional Nuclear Telomere Organization in Multiple Myeloma

Area of Science:

• Oncology
• Genetics
• Cell Biology

Background:

• Multiple myeloma (MM) is a plasma cell malignancy preceded by monoclonal gammopathy of undetermined significance (MGUS).
• Predicting disease progression and treatment response in MGUS and MM remains challenging.
• Nuclear telomeric architecture is a potential biomarker for disease state.

Purpose of the Study:

• To investigate the utility of three-dimensional (3D) telomere analysis in differentiating disease stages of multiple myeloma (MM).
• To explore the potential of 3D telomere profiling for risk stratification and personalized treatment decisions in MM.
• To assess if telomeric profiles differ between blood and bone marrow samples in MM patients.

Main Methods:

• Collected samples from patients diagnosed with MGUS, MM, and relapsed MM.
• Performed three-dimensional (3D) telomere analysis.
• Quantified telomere signal intensity, number of telomere aggregates, nuclear volume, and telomere distribution (a/c ratio).

Main Results:

• Telomeric profiles successfully differentiated between MGUS, MM, and relapsed MM stages.
• Identical telomeric profiles were observed in myeloma cells from both blood and bone marrow aspirates.
• Specific telomere parameters (intensity, aggregates, volume, distribution) were key discriminators.

Conclusions:

• 3D telomere profiling is a promising method for distinguishing between different stages of multiple myeloma.
• This technique holds potential for improving risk stratification and guiding personalized treatment strategies for MM patients.
• Telomere analysis in blood samples may be a viable alternative to bone marrow analysis for MM assessment.